Avid Bioservices, Inc.
CDMO · NASDAQ
10/31/2024 | 7/31/2024 | 4/30/2024 | 1/31/2024 | |
|---|---|---|---|---|
| Revenue | $33,482 | $40,173 | $42,975 | $33,815 |
| % Growth | -16.7% | -6.5% | 27.1% | – |
| Cost of Goods Sold | $35,527 | $34,460 | $37,475 | $31,432 |
| Gross Profit | -$2,045 | $5,713 | $5,500 | $2,383 |
| % Margin | -6.1% | 14.2% | 12.8% | 7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $5,994 | $0 |
| SG&A Expenses | $10,586 | $8,169 | $6,794 | $6,382 |
| Sales & Mktg Exp. | $0 | $0 | $800 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $10,586 | $8,169 | $6,794 | $6,382 |
| Operating Income | -$12,631 | -$2,456 | -$1,294 | -$3,999 |
| % Margin | -37.7% | -6.1% | -3% | -11.8% |
| Other Income/Exp. Net | -$4,775 | -$3,078 | -$3,936 | -$3,059 |
| Pre-Tax Income | -$17,406 | -$5,534 | -$5,230 | -$7,058 |
| Tax Expense | $0 | $0 | $117,874 | -$1,052 |
| Net Income | -$17,406 | -$5,534 | -$123,104 | -$6,006 |
| % Margin | -52% | -13.8% | -286.5% | -17.8% |
| EPS | -0.27 | -0.087 | -1.94 | -0.095 |
| % Growth | -210.3% | 95.5% | -1,944.3% | – |
| EPS Diluted | -0.27 | -0.087 | -1.94 | -0.095 |
| Weighted Avg Shares Out | 63,838 | 63,639 | 63,496 | 63,321 |
| Weighted Avg Shares Out Dil | 63,838 | 63,639 | 63,496 | 63,321 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3,276 | $2,454 | $1,810 | $875 |
| Depreciation & Amortization | $3,972 | $2,824 | $2,859 | $2,927 |
| EBITDA | -$10,158 | -$256 | -$561 | -$3,256 |
| % Margin | -30.3% | -0.6% | -1.3% | -9.6% |